
Stendra Boosts Sexual Health in Men with Hematological Disorders: A 3-Year Study
Reading Time: 2 minutes Introduction Sexual health is a critical component of overall well-being, yet it is often compromised in men suffering from hematological disorders. These conditions can lead to a range of complications, including erectile dysfunction (ED), which can significantly impact quality of life. Stendra (avanafil), a phosphodiesterase type 5 (PDE5) inhibitor, has been recognized for its efficacy in treating ED. This article presents findings from a three-year observational study examining the effects of Stendra on sexual desire and performance in American men with hematological disorders. Study Design and Participants The study involved 250 American men aged between 30 and 70 years, diagnosed...